This study is currently recruiting participants.
Number
02-C-0179
Sponsoring Institute
National Cancer Institute (NCI)
Recruitment Detail
Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: 18 Years Max Age: N/A
Referral Letter Required
No
Population Exclusion(s)
Children;Adults who are or may become unable to consent;Pregnant Women;Fetuses;Neonates
Keywords
Suppressor Cells; T-cells; CD4+ / CD25+ cells; Natural History
Recruitment Keyword(s)
Cancer; Malignancy; Blood Sample
Condition(s)
Prostate Cancer; Breast Cancer; Colon Cancer; Lung Cancer; Liver Cancer
Investigational Drug(s)
None
Investigational Device(s)
Intervention(s)
Supporting Site
National Cancer Institute
Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.
--Back to Top--
INCLUSION CRITERIA: Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible. Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol. Ability to understand and the willingness to sign a written informed consent document. INCLUSION FOR APHERESIS: Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference. Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3) Weight greater than 25 kg HIV negative Prothrombin Time within normal limits Partial Thromboplastin Time within normal limits Medically indicated central line in place or adequate peripheral venous access EXCLUSION CRITERIA: Children will not be eligible.
Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible.
Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol.
Ability to understand and the willingness to sign a written informed consent document.
INCLUSION FOR APHERESIS:
Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference.
Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3)
Weight greater than 25 kg
HIV negative
Prothrombin Time within normal limits
Partial Thromboplastin Time within normal limits
Medically indicated central line in place or adequate peripheral venous access
EXCLUSION CRITERIA:
Children will not be eligible.
Principal Investigator
Referral Contact
For more information: